Picture of Hikma Pharmaceuticals logo

HIK Hikma Pharmaceuticals News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

UK's Hikma shares tumble on medium-term profit forecast cut

** Shares of British drugmaker Hikma Pharmaceuticals HIK.L fall ~11.5% to 1,568p

** HIK top loser in FTSE 100 .FTSE index

** Co cuts medium-term core operating profit growth forecast to 5% to 7%, down from the previous outlook of 7% to 9%

** Co expects medium-term compounded annual revenue growth to be at the lower end of the 6% to 8% range

** Up to Wednesday close, HIK down 11.14% YTD, compared with a 19.57% increase in FTSE

(Reporting by Unnamalai L in Bengaluru)

((Unnamalai.L@thomsonreuters.com;))

Recent news on Hikma Pharmaceuticals

See all news